Biohit Oyj Class B

As of June 30, 2016, Biohit Oyj Class B carries a market capitalization of 72.76M, placing it among publicly traded companies globally. Its enterprise value stands at 64.76M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Biohit Oyj Class B's next confirmed earnings release is scheduled for February 17, 2027.

As of June 30, 2016, Biohit Oyj Class B has 14.70M shares outstanding.

These figures are as of June 30, 2016.

As of June 30, 2016, Biohit Oyj Class B maintains a current ratio of 6.56, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2016.

Over the twelve months ended June 30, 2016, Biohit Oyj Class B recorded 14,000.00 in income tax expense.

As of the close on October 22, 2026, Biohit Oyj Class B's stock has declined approximately 29.81% over the past 52 weeks. The 50-day moving average sits at 2.43, while the 200-day moving average is 2.61.

As of June 30, 2016, Biohit Oyj Class B holds 8.10M in cash and equivalents against 100,000.00 in total debt, resulting in a net debt position of -400,000.00. Total book value stands at 10.90M, with working capital of 8.90M providing operational flexibility.

These figures cover the twelve months ended June 30, 2016.